Last reviewed · How we verify
NCT03169517
Blood Flow Index as an Indicator of Successful Peripheral Nerve Block
trial in Laser in 110 participants. Completed in 4 September 2017.
4 September 2017
Quick facts
| Lead sponsor | Huazhong University of Science and Technology |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 110 |
| Start date | 27 May 2017 |
| Primary completion | 4 September 2017 |
| Estimated completion | 4 September 2017 |
| Sites | 1 location across China |
Conditions studied
- Laser — all drugs for Laser →
Sponsor
Huazhong University of Science and Technology
Who can join
Adults 18 to 75, any sex, with Laser. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Laser speckle contrast imaging (LSCI) allows real-time, non-invasive, quantitative measurements of regional blood flow. The aim of this prospective observational study was to evaluate the blood flow changes by LSCI after peripheral nerve block and determine whether this novel optical technique can be used as a reliable indicator of successful blocks.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Blood flow index as an indicator of successful sciatic nerve block: a prospective observational study using laser speckle contrast imaging.
Wu X, Li J, Joypaul K, Bao WW, et al · · 2018 · cited 8× · PMID 30236247 · DOI 10.1016/j.bja.2018.05.065
Verify or expand the search:
- PubMed search for NCT03169517
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Laser
Currently open trials in the same condition.
- NCT07519421 — Different Laser Frequencies on Neuropathic Outcomes in Patients With Bell's Palsy · NA · recruiting
- NCT07566507 — High-Energy Laser in the Conservative Treatment of Rhizarthrosis · NA · recruiting
- NCT07467954 — Comparative Effectiveness of Long-Pulsed 1064-nm Nd:YAG and Fractional CO₂ Laser in Skin Rejuvenation · NA · recruiting
- NCT07517601 — Erbium-doped Yttrium Aluminum Garnet (Er:YAG) Laser vs Conventional Ceramic Bracket Debonding: A Split-Mouth Clinical Tr · NA · active not recruiting
- NCT07351747 — Effect of Laser Acupoints on Fallopian Tube Obstruction · NA · recruiting
Other Huazhong University of Science and Technology trials
Trials by the same sponsor.
- NCT07502027 — A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Tr · Phase 4 · not yet recruiting
- NCT07502014 — A Clinical Study of Iparomlimab and Tuvonralimab Combined With Fruquintinib and Heterogeneous Radiotherapy Versus Fruqui · Phase 2 · not yet recruiting
- NCT07509866 — Liposomal Bupivacaine Versus Ropivacaine With Perineural Dexamethasone or Dexmedetomidine as Adjuncts for Adductor Canal · NA · recruiting
- NCT07326943 — Minimum Effective Dose of Ropivacaine for Ultrasound-guided Interscalene Block · NA · recruiting
- NCT07229976 — Clinical Efficacy of Thumbtack Needle for Chronic Insomnia in Perimenopausal and Menopausal Women · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03169517 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Huazhong University of Science and Technology
- Last refreshed: 6 September 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03169517.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing